In this video interview, David Morton, PhD, director of biostatistics at Certara, reflects on the growing role of Bayesian ...
Evaluation of the HER/PI3K/AKT Family Signaling Network as a Predictive Biomarker of Pathologic Complete Response for Patients With Breast Cancer Treated With Neratinib in the I-SPY 2 TRIAL BaSyc is ...
As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more flexible, data-driven approaches that integrate prior knowledge, reduce sample ...
WILMINGTON, N.C. & COLLEGE STATION, Texas--(BUSINESS WIRE)-- PPD, Inc. (Nasdaq: PPDI) and Berry Consultants, LLC today announced they have entered into a collaboration in the area of Bayesian ...
Health care is undergoing an important and well-needed shift from a one-size-fits-all approach to more personalized, precise, patient-focused care. A similar approach needs to be implemented at scale ...
The US Food and Drug Administration (FDA) last week finalized guidance on adaptive clinical trial designs for drugs and biologics. The 33-page guidance, which finalizes a draft version released for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results